HALEY HARKENDORFF: Open Payments
NPI 1447622592 · GOLDEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$804 in 31 payments from 12 companies in 2025. Trend: 2023 $1,073 · 2024 $853 · 2025 $804
Food & beverage: $704Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $187 |
| Novartis Pharmaceuticals Corporation | 5 | $179 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
| GENZYME CORPORATION | 3 | $79 |
| ABBVIE INC. | 2 | $38 |
| Organon LLC | 4 | $28 |
| LEO Pharma Inc. | 1 | $27 |
| Almirall LLC | 1 | $26 |
| Kerecis Limited | 1 | $23 |
Products named: TREMFYA, DUPIXENT, COSENTYX, BLU-U, ANZUPGO, Cordran, Kerecis SurgiClose, SKYRIZI.
Industry payments across CO — which companies pay providers there.
